Adragos Pharma

Adragos Pharma is a global CDMO headquartered in Munich, Germany, focused on the development and manufacturing of pharmaceutical products. The company is building a differentiated international network across Europe and Japan, with a strong focus on sterile injectables and complex dosage forms. Adragos operates manufacturing sites in France, Germany, Switzerland, and Japan, as well as a development site in Greece, and is backed by FSN Capital and the Prange Family Office.